Grants for Research Projects, 34655-34657 [E7-12223]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 121 / Monday, June 25, 2007 / Proposed Rules
for information on where and how to
submit applications.
To be effective, the size of the
committee will be limited. Each
organization affected by emergency
alarm systems on passenger vessels
need not have its own representative on
the committee. Rather, each interest
must be adequately represented and the
membership must be fairly balanced.
After reviewing the comments
received in response to this notice and
any applications for membership, the
Board will issue a notice in the Federal
Register announcing the establishment
of the committee and the committee
membership, unless it is determined
based on comments that the
establishment of the committee would
be inappropriate. The first committee
meeting is tentatively scheduled for
August 15 and 16, 2007 at the Access
Board offices in Washington, DC.
The Board expects the committee to
hold no more than three meetings and
all meetings will be in the Washington,
DC area. The meetings will be open to
the public. Future committee meetings
will be announced in the Federal
Register.
The Board will provide staff support
to the committee. Members of the
committee will not be compensated for
their service. The Board may pay travel
expenses for a limited number of
persons who would otherwise be unable
to serve on the committee. Members
will not be considered special
government employees since they will
serve as representatives of their
organizations and will not be required
to file confidential financial disclosure
reports.
rmajette on PROD1PC64 with PROPOSALS
Availability of Copies and Electronic
Access
15:43 Jun 22, 2007
Jkt 211001
Tricia Mason,
Chair, Architectural and Transportation
Barriers Compliance Board.
[FR Doc. E7–12196 Filed 6–22–07; 8:45 am]
BILLING CODE 8150–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
42 CFR Part 52
RIN 0925–AA42
Grants for Research Projects
National Institutes of Health,
Department of Health and Human
Services.
ACTION: Notice of proposed rulemaking.
AGENCY:
SUMMARY: The National Institutes of
Health (NIH) proposes to amend the
existing regulations governing grants for
research projects by revising the
definition of Principal Investigator to
mean one or more individuals
designated by the grantee in the grant
application and approved by the
Secretary, who is or are responsible for
the scientific and technical direction of
the project, rather than limiting the role
of principal investigator to one single
individual, and the conditions for
multiple or concurrent awards
permitting the Secretary to evaluate,
approve and make one or more awards
pursuant to one or more applications.
DATES: Comments must be received on
or before August 24, 2007 in order to
assure that NIH will be able to consider
the comments in preparing the final
rule.
Persons and organizations
interested in submitting comments,
identified by RIN 0925–AA42, may do
so by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• E-mail: jm40z@nih.gov. Include RIN
number 0925–AA42 in the subject line
of the message.
• Fax: 301–402–0169.
• Mail: Jerry Moore, NIH Regulations
Officer, Office of Management
Assessment, National Institutes of
Health, 6011 Executive Boulevard, Suite
601, MSC 7669, Rockville, MD 20892.
• Hand Delivery/Courier: 6011
Executive Boulevard, Suite 601,
Rockville, MD 20892.
FOR FURTHER INFORMATION CONTACT: Jerry
Moore at the address above, or
ADDRESSES:
Single copies of this publication may
be obtained at no cost by calling the
Access Board’s automated publications
order line (202) 272–0080, by pressing
2 on the telephone keypad and then
please record your name, address, city,
State, zip code, telephone number and
request the emergency alarms advisory
committee notice. Persons using a TTY
should call (202) 272–0082. This
document is available in alternate
formats upon request. Persons who want
this publication in an alternate format
should specify the type of format
(cassette tape, Braille, large print, or
ASCII disk). This document is also
VerDate Aug<31>2005
available on the Board’s Web site
(https://www.access-board.gov).
PO 00000
Frm 00012
Fmt 4702
Sfmt 4702
34655
telephone 301–496–4607 (not a toll-free
number).
SUPPLEMENTARY INFORMATION: On
September 30, 2003, NIH Director Elias
A. Zerhouni announced a series of farreaching strategic initiatives known
collectively as the NIH Roadmap for
Medical Research (NIH Roadmap). The
NIH Roadmap is an innovative approach
designed to transform the nation’s
medical research capabilities and
accelerate fundamental research
discovery and translation of that
knowledge into effective prevention
strategies and new treatments. One of
the NIH Roadmap initiatives encourages
interdisciplinary research and team
science and includes a recommendation
to modify grant and research contract
applications to allow proposing of more
than one Principal Investigator when
appropriate. This is congruent with the
January 4, 2005, directive issued by the
President’s Office of Science and
Technology Policy (OSTP) to all Federal
research agency heads instructing the
heads to accommodate the recognition
of two or more Principal Investigators
on research projects (grants and
contacts). While this new OSTP policy
does not prohibit the use of a single
Principal Investigator when that is most
appropriate for a particular research
project, it simply permits the
designation of more than one Principal
Investigator when that more accurately
reflects the management needs of a
research project.
For the purpose of implementing the
NIH Roadmap initiatives, the NIH plans
to modify research grant and contract
applications to request information on
more than one Principal Investigator,
consistent with the new OSTP policy
establishing the appropriateness of
multiple Principal Investigators.
Accordingly, we propose to revise the
definition of the term Principal
Investigator set forth in § 52.2 of the
Grants for Research Projects regulations
codified at 42 CFR Part 52, and the
conditions for multiple or concurrent
awards permitting the Secretary to
evaluate, approve and make one or more
awards pursuant to one or more
applications.
Specifically, in this Notice of
Proposed Rulemaking (NPRM) we
propose to amend the existing
regulations governing grants for research
projects by revising the definition of
Principal Investigator so that it does not
limit the role of Principal Investigator to
one single individual.
As announced in NIH notice number
NOT–OD–07–017 (https://grants.nih.gov/
grants/guide/notice-files/NOT-OD-07017.html), these individual(s) must be
E:\FR\FM\25JNP1.SGM
25JNP1
rmajette on PROD1PC64 with PROPOSALS
34656
Federal Register / Vol. 72, No. 121 / Monday, June 25, 2007 / Proposed Rules
judged by the applicant organization to
have the appropriate level of authority
and responsibility to direct the project
or program supported by the grant in
order to be considered Principal
Investigator(s). While this rule would
permit the applicant organization to
designate multiple individuals as
Principal Investigators who share the
authority and responsibility for leading
and directing the project, intellectually
and logistically, each Principal
Investigator is responsible and
accountable to the applicant
organization (or, as appropriate, to a
collaborating organization), for the
proper conduct of the project or
program, including the submission of all
required reports. In other words, the
presence of more than one identified
Principal Investigator on an application
or award diminishes neither the
responsibility nor the accountability of
any individual Principal Investigator.
Additionally, we propose to amend
§ 52.6 by revising paragraph (d)
permitting the Secretary to evaluate,
approve and make one or more awards
pursuant to one or more applications.
Under current regulations, the
Secretary is permitted to evaluate,
approve and make more than one award
pursuant to two or more applications. In
some cases, however, it may be
desirable to disaggregate a single
application to make more than one
award. For example, in the case of an
application for support of a project that
involves more than one Principal
Investigator affiliated with more than
one institution, it may be desirable to
administer the project with more than
one award. In addition, applications
that involve subprojects may be
disaggregated into separate awards to
improve scientific management. The
revised regulatory language clarifies
options and provides an opportunity to
contemplate more than one award that
may involve more than one institution
in response to a single application. In
some of these cases separate records
will be associated in the NIH data
system so that the components can be
managed as a single project to promote
close collaboration with their
counterparts. Actual awards also will be
associated through special terms of
award to clearly note collaborations and
any special requirements resulting from
such collaborations, In other cases, it
may be appropriate to consider multiple
applications from more than one
institutions that are managed as a single
unit with multiple awards to the
different institutions to facilitate
collaboration. This change will foster
interdisciplinary and collaborative
research and will improve management
VerDate Aug<31>2005
15:11 Jun 22, 2007
Jkt 211001
flexibility even when components of
such collaborative research programs
are administered by different NIH
awarding components.
The purpose of this NPRM is to invite
public comment on the proposed
regulation. The following is provided as
public information.
under the Executive Order and
determined that it does not have any
federalism implications. The Director,
NIH, certifies that the proposed rule will
not have an effect on the States, or on
the distribution of power and
responsibilities among the various
levels of government.
Executive Order 12866
Executive Order 12866 requires that
all regulatory actions reflect
consideration of the costs and benefits
they generate, and that they meet certain
standards, such as avoiding the
imposition of unnecessary burdens on
the affected public. If a regulatory action
is deemed to fall within the scope of the
definition of the term ‘‘significant
regulatory action’’ contained in § 3(f) of
the Order, prepublication review by the
Office of Management and Budget’s
Office of Information and Regulatory
Affairs (OIRA) is necessary. This
proposed rule was reviewed under
Executive Order 12866 by OIRA and
was deemed significant.
Executive Order 12866 also requires
each agency to write all rules in plain
language. In addition to your
substantive comments on this proposed
rule, we invite comments on how to
make this proposed rule easier to
understand. For example:
• Have we organized the material to
suit your needs?
• Are the requirements in the rule
clearly stated?
• Does the rule contain technical
language or jargon that is not clear?
• Would a different format (grouping
and order of sections, use of headings,
paragraphing) make the rule easier to
understand?
• Could we improve clarity by adding
illustrative examples, tables, lists, or
diagrams?
• What else could we do to make the
rule easier to understand.?
Paperwork Reduction Act
Regulatory Flexibility Act
The Regulatory Flexibility Act of 1980
(5 U.S.C. chapter 6) requires that
regulatory proposals be analyzed to
determine whether they create a
significant impact on a substantial
number of small entities. The Director,
NIH, certifies that any final rule
resulting from this proposed rule will
not have any such impact.
Executive Order 13132
Executive Order 13132, Federalism,
requires that federal agencies consult
with State and local government
officials in the development of
regulatory policies with federalism
implications. The Director, NIH,
reviewed the proposed rule as required
PO 00000
Frm 00013
Fmt 4702
Sfmt 4702
This proposed rule does not contain
any information collection requirements
which are subject to Office of
Management and Budget (OMB)
approval under the Paperwork
Reduction Act of 1995 (44 U.S.C.
chapter 35).
Catalog of Federal Domestic Assistance
The Catalog of Federal Domestic
Assistance numbered programs affected
by the proposed regulations are:
93.113—Biological Response to
Environmental Health Hazards
93.114—Applied Toxicological
Research and Testing
93.115—Biometry and Risk EstimationHealth Risks from Environmental
Exposures
93.118—Acquired Immunodeficiency
Syndrome (AIDS) Activity
93.121—Oral Diseases and Disorders
Research
93.135—Centers for Research and
Demonstration for Health Promotion
and Disease Prevention
93.136—Injury Prevention and Control
Research and State and Community
Based Programs
93.172—Human Genome Research
93.173—Research Related to Deafness
and Communication Disorders
93.184—Disabilities Prevention
93.213—Research and Training in
Complementary and Alternative
Medicine
93.242—Mental Health Research Grants
93.262—Occupational Safety and Health
Program
93.271—Alcohol Research Career
Development Awards for Scientists
and Clinicians
93.273—Alcohol Research Programs
93.279—Drug Abuse and Addiction
Research Programs
93.281—Mental Health Research Career/
Scientist Development Awards
93.283—Centers for Disease Control and
Prevention-Investigations and
Technical Assistance
93.361—Nursing Research
93.389—National Center for Research
Sources
93.390—Academic Research
Enhancement Award
93.393—Cancer Cause and Prevention
Research
93.394—Cancer Detection and Diagnosis
Research
E:\FR\FM\25JNP1.SGM
25JNP1
Federal Register / Vol. 72, No. 121 / Monday, June 25, 2007 / Proposed Rules
93.395—Cancer Treatment Research
93.396—Cancer Biology Research
93.821—Biophysics and Physiological
Sciences Research
93.837—Heart and Vascular Diseases
Research
93.838—Lung Diseases Research
93.839—Blood Diseases and Resources
Research
93.846—Arthritis, Musculoskeletal and
Skin Diseases Research
93.847—Diabetes, Endocrinology and
Metabolism Research
93.848—Digestive Diseases and
Nutrition Research
93.849—Kidney Diseases, Urology and
Hematology Research
93.853—Clinical Research Related to
Neurological Disorders
93.855—Allergy, Immunology and
Transplantation Research
93.856—Microbiology and Infectious
Diseases Research
93.859—Biomedical Research and
Research Training
93.865—Research for Mothers and
Children
93.866—Aging Research
93.867—Vision Research
93.879—Medical Library Assistance
93.929—Center for Medical
Rehabilitation Research
93.934—Fogarty International Center
Research Collaboration Award
93.939—Blood Diseases and Resources
Research
93.941—HIV Demonstration, Research,
Public and Professional Education
Projects
93.942—Research, Treatment and
Education Programs on Lyme Disease
in the United States
93.943—Epidemiologic Research
Studies of Acquired
Immunodeficiency Syndrome (AIDS)
and Human Immunodeficiency Virus
(HIV) Infection in Selected Population
Groups
93.947—Tuberculosis Demonstration,
Research, Public and Professional
Education
List of Subjects in 42 CFR Part 52
rmajette on PROD1PC64 with PROPOSALS
Authority: 42 U.S.C. 216.
1A. We propose to amend § 52.2 by
revising the definition of the term
‘‘Principal investigator’’ to read as
follows:
§ 52.2
Definitions.
*
*
*
*
*
Principal investigator means the
individual(s) judged by the applicant
organization to have the appropriate
level of authority and responsibility to
direct the project or program supported
by the grant and who is or are
responsible for the scientific and
technical direction of the project.
*
*
*
*
*
2. We propose to amend § 52.6 by
revising paragraph (d) to read as
follows:
§ 52.6
Grant awards.
*
*
*
*
*
(d) Multiple or concurrent awards.
Whenever a research project involves a
number of different but related
problems, activities or disciplines
which require evaluation by different
groups, or whenever support for a
project could be more effectively
administered by separate handling of
separate aspects of the project, the
Secretary may evaluate, approve and
make one or more awards pursuant to
one or more applications.
*
*
*
*
*
[FR Doc. E7–12223 Filed 6–22–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
Fish and Wildlife Service,
Interior.
ACTION: Notice of an amended 12-month
petition finding.
AGENCY:
Editorial Note: This document was
received by the Office of the Federal Register
on June 20, 2007.
For reasons presented in the
preamble, it is proposed to amend part
Jkt 211001
1. The authority citation for part 52
continues to read as follows:
Endangered and Threatened Wildlife
and Plants; 12-Month Finding on a
Petition To List the Sierra Nevada
Distinct Population Segment of the
Mountain Yellow-Legged Frog (Rana
muscosa)
Dated: May 11, 2006.
Elias A. Zerhouni,
Director, National Institutes of Health.
Approved: October 12, 2006.
Michael O. Leavitt,
Secretary.
15:11 Jun 22, 2007
PART 52—GRANTS FOR RESEARCH
PROJECTS
50 CFR Part 17
Grant programs—Health; Medical
research; Occupational safety and
health.
VerDate Aug<31>2005
52 of title 42 of the Code of Federal
Regulations as set forth below.
SUMMARY: We, the U.S. Fish and
Wildlife Service (Service), announce an
amended 12-month finding on a petition
PO 00000
Frm 00014
Fmt 4702
Sfmt 4702
34657
to list the Sierra Nevada distinct
population segment (DPS) of the
mountain yellow-legged frog (Rana
muscosa) under the Endangered Species
Act of 1973, as amended (Act). We are
amending our previous 12-month
petition finding, which found that
listing is warranted but precluded, by
revising the preclusion and expeditious
progress section of that finding.
DATES: The finding announced in this
document was made on June 25, 2007.
ADDRESSES: Supporting documentation
used in the development of this
amended 12-month finding will be
available for inspection, by
appointment, during normal business
hours at the Endangered Species
Program, Division of Conservation and
Classification, U.S. Fish and Wildlife
Service, 4401 N. Fairfax Drive, Room
420, Arlington, VA 22203. Comments
and materials received, as well as
supporting documentation used in the
development of the initial 12-month
finding published on January 16, 2003
(68 FR 2283), are available for
inspection, by appointment, during
normal business hours at the
Sacramento Fish and Wildlife Office,
U.S. Fish and Wildlife Service, 2800
Cottage Way, Room W–2605,
Sacramento, CA 95825.
FOR FURTHER INFORMATION CONTACT:
Chris Nolin, Chief, Division of
Conservation and Classification,
Endangered Species Program (see
ADDRESSES section) (telephone 703–
358–2171). Persons who use a
telecommunications device for the deaf
(TDD) may call the Federal Information
Relay Service (FIRS) at 1–800–877–
8339, 24 hours a day, 7 days a week.
SUPPLEMENTARY INFORMATION:
Background
Section 4(b)(3)(B) of the Endangered
Species Act of 1973, as amended (Act)
(16 U.S.C. 1531 et seq.), requires that,
for any petition to revise the Lists of
Endangered and Threatened Wildlife
and Plants that contains substantial
scientific or commercial information
that the petitioned action may be
warranted, we make a finding within 12
months of the date of the receipt of the
petition on whether the petitioned
action is: (a) Not warranted, (b)
warranted, or (c) warranted, but that the
immediate proposal of a regulation
implementing the petitioned action is
precluded by other pending proposals to
determine whether any species is
threatened or endangered, and
expeditious progress is being made to
add or remove qualified species from
the Lists of Endangered and Threatened
Wildlife and Plants (Lists). Such 12-
E:\FR\FM\25JNP1.SGM
25JNP1
]]>Agencies
[Federal Register Volume 72, Number 121 (Monday, June 25, 2007)]
[Proposed Rules]
[Pages 34655-34657]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-12223]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
42 CFR Part 52
RIN 0925-AA42
Grants for Research Projects
AGENCY: National Institutes of Health, Department of Health and Human
Services.
ACTION: Notice of proposed rulemaking.
-----------------------------------------------------------------------
SUMMARY: The National Institutes of Health (NIH) proposes to amend the
existing regulations governing grants for research projects by revising
the definition of Principal Investigator to mean one or more
individuals designated by the grantee in the grant application and
approved by the Secretary, who is or are responsible for the scientific
and technical direction of the project, rather than limiting the role
of principal investigator to one single individual, and the conditions
for multiple or concurrent awards permitting the Secretary to evaluate,
approve and make one or more awards pursuant to one or more
applications.
DATES: Comments must be received on or before August 24, 2007 in order
to assure that NIH will be able to consider the comments in preparing
the final rule.
ADDRESSES: Persons and organizations interested in submitting comments,
identified by RIN 0925-AA42, may do so by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
E-mail: jm40z@nih.gov. Include RIN number 0925-AA42 in the
subject line of the message.
Fax: 301-402-0169.
Mail: Jerry Moore, NIH Regulations Officer, Office of
Management Assessment, National Institutes of Health, 6011 Executive
Boulevard, Suite 601, MSC 7669, Rockville, MD 20892.
Hand Delivery/Courier: 6011 Executive Boulevard, Suite
601, Rockville, MD 20892.
FOR FURTHER INFORMATION CONTACT: Jerry Moore at the address above, or
telephone 301-496-4607 (not a toll-free number).
SUPPLEMENTARY INFORMATION: On September 30, 2003, NIH Director Elias A.
Zerhouni announced a series of far-reaching strategic initiatives known
collectively as the NIH Roadmap for Medical Research (NIH Roadmap). The
NIH Roadmap is an innovative approach designed to transform the
nation's medical research capabilities and accelerate fundamental
research discovery and translation of that knowledge into effective
prevention strategies and new treatments. One of the NIH Roadmap
initiatives encourages interdisciplinary research and team science and
includes a recommendation to modify grant and research contract
applications to allow proposing of more than one Principal Investigator
when appropriate. This is congruent with the January 4, 2005, directive
issued by the President's Office of Science and Technology Policy
(OSTP) to all Federal research agency heads instructing the heads to
accommodate the recognition of two or more Principal Investigators on
research projects (grants and contacts). While this new OSTP policy
does not prohibit the use of a single Principal Investigator when that
is most appropriate for a particular research project, it simply
permits the designation of more than one Principal Investigator when
that more accurately reflects the management needs of a research
project.
For the purpose of implementing the NIH Roadmap initiatives, the
NIH plans to modify research grant and contract applications to request
information on more than one Principal Investigator, consistent with
the new OSTP policy establishing the appropriateness of multiple
Principal Investigators. Accordingly, we propose to revise the
definition of the term Principal Investigator set forth in Sec. 52.2
of the Grants for Research Projects regulations codified at 42 CFR Part
52, and the conditions for multiple or concurrent awards permitting the
Secretary to evaluate, approve and make one or more awards pursuant to
one or more applications.
Specifically, in this Notice of Proposed Rulemaking (NPRM) we
propose to amend the existing regulations governing grants for research
projects by revising the definition of Principal Investigator so that
it does not limit the role of Principal Investigator to one single
individual.
As announced in NIH notice number NOT-OD-07-017 (https://
grants.nih.gov/grants/guide/notice-files/NOT-OD-07-017.html), these
individual(s) must be
[[Page 34656]]
judged by the applicant organization to have the appropriate level of
authority and responsibility to direct the project or program supported
by the grant in order to be considered Principal Investigator(s). While
this rule would permit the applicant organization to designate multiple
individuals as Principal Investigators who share the authority and
responsibility for leading and directing the project, intellectually
and logistically, each Principal Investigator is responsible and
accountable to the applicant organization (or, as appropriate, to a
collaborating organization), for the proper conduct of the project or
program, including the submission of all required reports. In other
words, the presence of more than one identified Principal Investigator
on an application or award diminishes neither the responsibility nor
the accountability of any individual Principal Investigator.
Additionally, we propose to amend Sec. 52.6 by revising paragraph
(d) permitting the Secretary to evaluate, approve and make one or more
awards pursuant to one or more applications.
Under current regulations, the Secretary is permitted to evaluate,
approve and make more than one award pursuant to two or more
applications. In some cases, however, it may be desirable to
disaggregate a single application to make more than one award. For
example, in the case of an application for support of a project that
involves more than one Principal Investigator affiliated with more than
one institution, it may be desirable to administer the project with
more than one award. In addition, applications that involve subprojects
may be disaggregated into separate awards to improve scientific
management. The revised regulatory language clarifies options and
provides an opportunity to contemplate more than one award that may
involve more than one institution in response to a single application.
In some of these cases separate records will be associated in the NIH
data system so that the components can be managed as a single project
to promote close collaboration with their counterparts. Actual awards
also will be associated through special terms of award to clearly note
collaborations and any special requirements resulting from such
collaborations, In other cases, it may be appropriate to consider
multiple applications from more than one institutions that are managed
as a single unit with multiple awards to the different institutions to
facilitate collaboration. This change will foster interdisciplinary and
collaborative research and will improve management flexibility even
when components of such collaborative research programs are
administered by different NIH awarding components.
The purpose of this NPRM is to invite public comment on the
proposed regulation. The following is provided as public information.
Executive Order 12866
Executive Order 12866 requires that all regulatory actions reflect
consideration of the costs and benefits they generate, and that they
meet certain standards, such as avoiding the imposition of unnecessary
burdens on the affected public. If a regulatory action is deemed to
fall within the scope of the definition of the term ``significant
regulatory action'' contained in Sec. 3(f) of the Order,
prepublication review by the Office of Management and Budget's Office
of Information and Regulatory Affairs (OIRA) is necessary. This
proposed rule was reviewed under Executive Order 12866 by OIRA and was
deemed significant.
Executive Order 12866 also requires each agency to write all rules
in plain language. In addition to your substantive comments on this
proposed rule, we invite comments on how to make this proposed rule
easier to understand. For example:
Have we organized the material to suit your needs?
Are the requirements in the rule clearly stated?
Does the rule contain technical language or jargon that is
not clear?
Would a different format (grouping and order of sections,
use of headings, paragraphing) make the rule easier to understand?
Could we improve clarity by adding illustrative examples,
tables, lists, or diagrams?
What else could we do to make the rule easier to
understand.?
Regulatory Flexibility Act
The Regulatory Flexibility Act of 1980 (5 U.S.C. chapter 6)
requires that regulatory proposals be analyzed to determine whether
they create a significant impact on a substantial number of small
entities. The Director, NIH, certifies that any final rule resulting
from this proposed rule will not have any such impact.
Executive Order 13132
Executive Order 13132, Federalism, requires that federal agencies
consult with State and local government officials in the development of
regulatory policies with federalism implications. The Director, NIH,
reviewed the proposed rule as required under the Executive Order and
determined that it does not have any federalism implications. The
Director, NIH, certifies that the proposed rule will not have an effect
on the States, or on the distribution of power and responsibilities
among the various levels of government.
Paperwork Reduction Act
This proposed rule does not contain any information collection
requirements which are subject to Office of Management and Budget (OMB)
approval under the Paperwork Reduction Act of 1995 (44 U.S.C. chapter
35).
Catalog of Federal Domestic Assistance
The Catalog of Federal Domestic Assistance numbered programs
affected by the proposed regulations are:
93.113--Biological Response to Environmental Health Hazards
93.114--Applied Toxicological Research and Testing
93.115--Biometry and Risk Estimation-Health Risks from Environmental
Exposures
93.118--Acquired Immunodeficiency Syndrome (AIDS) Activity
93.121--Oral Diseases and Disorders Research
93.135--Centers for Research and Demonstration for Health Promotion and
Disease Prevention
93.136--Injury Prevention and Control Research and State and Community
Based Programs
93.172--Human Genome Research
93.173--Research Related to Deafness and Communication Disorders
93.184--Disabilities Prevention
93.213--Research and Training in Complementary and Alternative Medicine
93.242--Mental Health Research Grants
93.262--Occupational Safety and Health Program
93.271--Alcohol Research Career Development Awards for Scientists and
Clinicians
93.273--Alcohol Research Programs
93.279--Drug Abuse and Addiction Research Programs
93.281--Mental Health Research Career/Scientist Development Awards
93.283--Centers for Disease Control and Prevention-Investigations and
Technical Assistance
93.361--Nursing Research
93.389--National Center for Research Sources
93.390--Academic Research Enhancement Award
93.393--Cancer Cause and Prevention Research
93.394--Cancer Detection and Diagnosis Research
[[Page 34657]]
93.395--Cancer Treatment Research
93.396--Cancer Biology Research
93.821--Biophysics and Physiological Sciences Research
93.837--Heart and Vascular Diseases Research
93.838--Lung Diseases Research
93.839--Blood Diseases and Resources Research
93.846--Arthritis, Musculoskeletal and Skin Diseases Research
93.847--Diabetes, Endocrinology and Metabolism Research
93.848--Digestive Diseases and Nutrition Research
93.849--Kidney Diseases, Urology and Hematology Research
93.853--Clinical Research Related to Neurological Disorders
93.855--Allergy, Immunology and Transplantation Research
93.856--Microbiology and Infectious Diseases Research
93.859--Biomedical Research and Research Training
93.865--Research for Mothers and Children
93.866--Aging Research
93.867--Vision Research
93.879--Medical Library Assistance
93.929--Center for Medical Rehabilitation Research
93.934--Fogarty International Center Research Collaboration Award
93.939--Blood Diseases and Resources Research
93.941--HIV Demonstration, Research, Public and Professional Education
Projects
93.942--Research, Treatment and Education Programs on Lyme Disease in
the United States
93.943--Epidemiologic Research Studies of Acquired Immunodeficiency
Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in
Selected Population Groups
93.947--Tuberculosis Demonstration, Research, Public and Professional
Education
List of Subjects in 42 CFR Part 52
Grant programs--Health; Medical research; Occupational safety and
health.
Dated: May 11, 2006.
Elias A. Zerhouni,
Director, National Institutes of Health.
Approved: October 12, 2006.
Michael O. Leavitt,
Secretary.
Editorial Note: This document was received by the Office of the
Federal Register on June 20, 2007.
For reasons presented in the preamble, it is proposed to amend part
52 of title 42 of the Code of Federal Regulations as set forth below.
PART 52--GRANTS FOR RESEARCH PROJECTS
1. The authority citation for part 52 continues to read as follows:
Authority: 42 U.S.C. 216.
1A. We propose to amend Sec. 52.2 by revising the definition of
the term ``Principal investigator'' to read as follows:
Sec. 52.2 Definitions.
* * * * *
Principal investigator means the individual(s) judged by the
applicant organization to have the appropriate level of authority and
responsibility to direct the project or program supported by the grant
and who is or are responsible for the scientific and technical
direction of the project.
* * * * *
2. We propose to amend Sec. 52.6 by revising paragraph (d) to read
as follows:
Sec. 52.6 Grant awards.
* * * * *
(d) Multiple or concurrent awards. Whenever a research project
involves a number of different but related problems, activities or
disciplines which require evaluation by different groups, or whenever
support for a project could be more effectively administered by
separate handling of separate aspects of the project, the Secretary may
evaluate, approve and make one or more awards pursuant to one or more
applications.
* * * * *
[FR Doc. E7-12223 Filed 6-22-07; 8:45 am]
BILLING CODE 4140-01-P
